Jamie E Craig

🇠🇴 Flinders University

2 articles in GJC

Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The 'Bevacizumab in Trabeculectomy Study'.

John Landers, Sean Mullany, Mark M Hassall, Jamie E Craig

OphthalmologyMay 20260 citationsRandomized Controlled Trial

A study found a single intravitreal bevacizumab dose during trabeculectomy with MMC improved surgical success and reduced medication needs for 3 years, offering a new adjunct for glaucoma surgery.

Full abstract PubMed

Association of FOXC1 Duplications With Juvenile Open-Angle Glaucoma.

Giorgina E Maxwell, Joshua M Schmidt, Antonia Kolovos, Thi T Nguyen, Katherine Zamora-Alejo, Jonathan B Ruddle et al.

JAMA OphthalmolMay 20260 citationsCohort Study

FOXC1 gene duplications were found to be a common, highly penetrant cause of juvenile open-angle glaucoma, suggesting genetic testing for these duplications in JOAG patients.

Full abstract PubMed

All 2 articles loaded

Global Search

Jamie E Craig

Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The 'Bevacizumab in Trabeculectomy Study'.

Association of FOXC1 Duplications With Juvenile Open-Angle Glaucoma.